Request for Covid-19 Impact Assessment of this Report

Healthcare

Covid-19 Impact on Mycophenolate Mofetil Market , Global Research Reports 2020-2021

  • BMR3851445
  • 105 Pages
  • May 2020
  • Healthcare
Download Sample    Get Discount   
 
This report provides a complete quantitative data and qualitative analysis on the global market for Mycophenolate Mofetil. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.

Prior to COVID-19, the global market for Mycophenolate Mofetil was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Mycophenolate Mofetil is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.

This report covers market size and forecasts of Mycophenolate Mofetil, including the following market information:

Global Mycophenolate Mofetil Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)

Global Mycophenolate Mofetil Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)

Global Mycophenolate Mofetil Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)

Global Mycophenolate Mofetil Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)

Key market players

Major competitors identified in this market include Genentech, Teva, Sandoz, West Ward Pharmaceuticals, Accord Healthcare, Mylan, Strides Pharma, Jubilant Cadista, Alkem Laboratories, Akorn, Passauer Pharma GmbH, Par Pharmaceutical, etc.

Based on the Region:

Asia-Pacific (China, Japan, South Korea, India and ASEAN)

North America (US and Canada)

Europe (Germany, France, UK and Italy)

Rest of World (Latin America, Middle East & Africa)

Based on the Type:

Capsule

Tablet

Suspension

Injection

Based on the Application:

heart transplant

liver transplant

kidney transplant

1.1 Research Scope

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Mycophenolate Mofetil Industry

1.7 COVID-19 Impact: Mycophenolate Mofetil Market Trends

2 Global Mycophenolate Mofetil Quarterly Market Size Analysis

2.1 Mycophenolate Mofetil Business Impact Assessment - COVID-19

2.1.1 Global Mycophenolate Mofetil Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Mycophenolate Mofetil Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Mycophenolate Mofetil Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Mycophenolate Mofetil Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Mycophenolate Mofetil Factory Price by Manufacturers

3.3 Location of Key Manufacturers Mycophenolate Mofetil Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Mycophenolate Mofetil Market

3.5 Key Manufacturers Mycophenolate Mofetil Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Mycophenolate Mofetil Segments, By Type

4.1 Introduction

1.4.1 Capsule

1.4.2 Tablet

1.4.3 Suspension

1.4.4 Injection

4.2 By Type, Global Mycophenolate Mofetil Market Size, 2019-2021

4.2.1 By Type, Global Mycophenolate Mofetil Market Size by Type, 2020-2021

4.2.2 By Type, Global Mycophenolate Mofetil Price, 2020-2021

5 Impact of Covid-19 on Mycophenolate Mofetil Segments, By Application

5.1 Overview

5.5.1 heart transplant

5.5.2 liver transplant

5.5.3 kidney transplant

5.2 By Application, Global Mycophenolate Mofetil Market Size, 2019-2021

5.2.1 By Application, Global Mycophenolate Mofetil Market Size by Application, 2019-2021

5.2.2 By Application, Global Mycophenolate Mofetil Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Genentech

7.1.1 Genentech Business Overview

7.1.2 Genentech Mycophenolate Mofetil Quarterly Production and Revenue, 2020

7.1.3 Genentech Mycophenolate Mofetil Product Introduction

7.1.4 Genentech Response to COVID-19 and Related Developments

7.2 Teva

7.2.1 Teva Business Overview

7.2.2 Teva Mycophenolate Mofetil Quarterly Production and Revenue, 2020

7.2.3 Teva Mycophenolate Mofetil Product Introduction

7.2.4 Teva Response to COVID-19 and Related Developments

7.3 Sandoz

7.3.1 Sandoz Business Overview

7.3.2 Sandoz Mycophenolate Mofetil Quarterly Production and Revenue, 2020

7.3.3 Sandoz Mycophenolate Mofetil Product Introduction

7.3.4 Sandoz Response to COVID-19 and Related Developments

7.4 West Ward Pharmaceuticals

7.4.1 West Ward Pharmaceuticals Business Overview

7.4.2 West Ward Pharmaceuticals Mycophenolate Mofetil Quarterly Production and Revenue, 2020

7.4.3 West Ward Pharmaceuticals Mycophenolate Mofetil Product Introduction

7.4.4 West Ward Pharmaceuticals Response to COVID-19 and Related Developments

7.5 Accord Healthcare

7.5.1 Accord Healthcare Business Overview

7.5.2 Accord Healthcare Mycophenolate Mofetil Quarterly Production and Revenue, 2020

7.5.3 Accord Healthcare Mycophenolate Mofetil Product Introduction

7.5.4 Accord Healthcare Response to COVID-19 and Related Developments

7.6 Mylan

7.6.1 Mylan Business Overview

7.6.2 Mylan Mycophenolate Mofetil Quarterly Production and Revenue, 2020

7.6.3 Mylan Mycophenolate Mofetil Product Introduction

7.6.4 Mylan Response to COVID-19 and Related Developments

7.7 Strides Pharma

7.7.1 Strides Pharma Business Overview

7.7.2 Strides Pharma Mycophenolate Mofetil Quarterly Production and Revenue, 2020

7.7.3 Strides Pharma Mycophenolate Mofetil Product Introduction

7.7.4 Strides Pharma Response to COVID-19 and Related Developments

7.8 Jubilant Cadista

7.8.1 Jubilant Cadista Business Overview

7.8.2 Jubilant Cadista Mycophenolate Mofetil Quarterly Production and Revenue, 2020

7.8.3 Jubilant Cadista Mycophenolate Mofetil Product Introduction

7.8.4 Jubilant Cadista Response to COVID-19 and Related Developments

7.9 Alkem Laboratories

7.9.1 Alkem Laboratories Business Overview

7.9.2 Alkem Laboratories Mycophenolate Mofetil Quarterly Production and Revenue, 2020

7.9.3 Alkem Laboratories Mycophenolate Mofetil Product Introduction

7.9.4 Alkem Laboratories Response to COVID-19 and Related Developments

7.10 Akorn

7.10.1 Akorn Business Overview

7.10.2 Akorn Mycophenolate Mofetil Quarterly Production and Revenue, 2020

7.10.3 Akorn Mycophenolate Mofetil Product Introduction

7.10.4 Akorn Response to COVID-19 and Related Developments

7.11 Passauer Pharma GmbH

7.11.1 Passauer Pharma GmbH Business Overview

7.11.2 Passauer Pharma GmbH Mycophenolate Mofetil Quarterly Production and Revenue, 2020

7.11.3 Passauer Pharma GmbH Mycophenolate Mofetil Product Introduction

7.11.4 Passauer Pharma GmbH Response to COVID-19 and Related Developments

7.12 Par Pharmaceutical

7.12.1 Par Pharmaceutical Business Overview

7.12.2 Par Pharmaceutical Mycophenolate Mofetil Quarterly Production and Revenue, 2020

7.12.3 Par Pharmaceutical Mycophenolate Mofetil Product Introduction

7.12.4 Par Pharmaceutical Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Mycophenolate Mofetil Supply Chain Analysis

8.1.1 Mycophenolate Mofetil Supply Chain Analysis

8.1.2 Covid-19 Impact on Mycophenolate Mofetil Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Mycophenolate Mofetil Distribution Channels

8.2.2 Covid-19 Impact on Mycophenolate Mofetil Distribution Channels

8.2.3 Mycophenolate Mofetil Distributors

8.3 Mycophenolate Mofetil Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Mycophenolate Mofetil Assessment

Table 9. COVID-19 Impact: Mycophenolate Mofetil Market Trends

Table 10. COVID-19 Impact Global Mycophenolate Mofetil Market Size

Table 11. Global Mycophenolate Mofetil Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)

Table 12. Global Mycophenolate Mofetil Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)

Table 13. Global Mycophenolate Mofetil Quarterly Market Size, 2020 (US$ Million) & (K MT)

Table 14. Global Mycophenolate Mofetil Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Mycophenolate Mofetil Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)

Table 16. Global Mycophenolate Mofetil Market Growth Drivers

Table 17. Global Mycophenolate Mofetil Market Restraints

Table 18. Global Mycophenolate Mofetil Market Opportunities

Table 19. Global Mycophenolate Mofetil Market Challenges

Table 20. Key Manufacturers Mycophenolate Mofetil Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Mycophenolate Mofetil Market Size, 2019 (K MT) & (US$ Million)

Table 22. Mycophenolate Mofetil Factory Price by Manufacturers 2020 (USD/MT)

Table 23. Location of Key Manufacturers Mycophenolate Mofetil Manufacturing Plants

Table 24. Key Manufacturers Mycophenolate Mofetil Market Served

Table 25. Date of Key Manufacturers Enter into Mycophenolate Mofetil Market

Table 26. Key Manufacturers Mycophenolate Mofetil Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Mycophenolate Mofetil Market Size by Type, 2020, (US$ Million)

Table 29. Global Mycophenolate Mofetil Market Size by Type, 2020 (K MT)

Table 30. Global Mycophenolate Mofetil Price: by Type, 2020-2021 (USD/MT)

Table 31. Global Mycophenolate Mofetil Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Mycophenolate Mofetil Market Size by Application, 2020-2021 (K MT)

Table 33. Global Mycophenolate Mofetil Price: by Application, 2020-2021 (USD/MT)

Table 34. Global Mycophenolate Mofetil Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Mycophenolate Mofetil Market Size by Region, 2019-2021 (K MT)

Table 36. By Country, North America Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Mycophenolate Mofetil Market Size, 2019-2021 (K MT)

Table 38. US Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million) & (K MT)

Table 39. Canada Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million) & (K MT)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Mycophenolate Mofetil Market Size, 2019-2021 (K MT)

Table 43. Germany Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million) & (K MT)

Table 44. France Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million) & (K MT)

Table 45. UK Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million) & (K MT)

Table 46. Italy Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million) & (K MT)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Mycophenolate Mofetil Market Size, 2019-2021 (K MT)

Table 50. China Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million) & (K MT)

Table 51. Japan Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million) & (K MT)

Table 52. South Korea Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million) & (K MT)

Table 53. India Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million) & (K MT)

Table 54. ASEAN Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million) & (K MT)

Table 55. Latin America Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million) & (K MT)

Table 56. Middle East and Africa Mycophenolate Mofetil Market Size, 2019-2021 (US$ Million) & (K MT)

Table 57. Genentech Business Overview

Table 58. Genentech Mycophenolate Mofetil Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Genentech Mycophenolate Mofetil Product

Table 60. Genentech Response to COVID-19 and Related Developments

Table 61. Teva Business Overview

Table 62. Teva Mycophenolate Mofetil Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Teva Mycophenolate Mofetil Product

Table 64. Teva Response to COVID-19 and Related Developments

Table 65. Sandoz Business Overview

Table 66. Sandoz Mycophenolate Mofetil Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Sandoz Mycophenolate Mofetil Product

Table 68. Sandoz Response to COVID-19 and Related Developments

Table 69. West Ward Pharmaceuticals Business Overview

Table 70. West Ward Pharmaceuticals Mycophenolate Mofetil Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. West Ward Pharmaceuticals Mycophenolate Mofetil Product

Table 72. West Ward Pharmaceuticals Response to COVID-19 and Related Developments

Table 73. Accord Healthcare Business Overview

Table 74. Accord Healthcare Mycophenolate Mofetil Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Accord Healthcare Mycophenolate Mofetil Product

Table 76. Accord Healthcare Response to COVID-19 and Related Developments

Table 77. Mylan Business Overview

Table 78. Mylan Mycophenolate Mofetil Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Mylan Mycophenolate Mofetil Product

Table 80. Mylan Response to COVID-19 and Related Developments

Table 81. Strides Pharma Business Overview

Table 82. Strides Pharma Mycophenolate Mofetil Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Strides Pharma Mycophenolate Mofetil Product

Table 84. Strides Pharma Response to COVID-19 and Related Developments

Table 85. Jubilant Cadista Business Overview

Table 86. Jubilant Cadista Mycophenolate Mofetil Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Jubilant Cadista Mycophenolate Mofetil Product

Table 88. Jubilant Cadista Response to COVID-19 and Related Developments

Table 89. Alkem Laboratories Business Overview

Table 90. Alkem Laboratories Mycophenolate Mofetil Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Alkem Laboratories Mycophenolate Mofetil Product

Table 92. Alkem Laboratories Response to COVID-19 and Related Developments

Table 93. Akorn Business Overview

Table 94. Akorn Mycophenolate Mofetil Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Akorn Mycophenolate Mofetil Product

Table 96. Akorn Response to COVID-19 and Related Developments

Table 97. Passauer Pharma GmbH Business Overview

Table 98. Passauer Pharma GmbH Mycophenolate Mofetil Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Passauer Pharma GmbH Mycophenolate Mofetil Product

Table 100. Passauer Pharma GmbH Response to COVID-19 and Related Developments

Table 101. Par Pharmaceutical Business Overview

Table 102. Par Pharmaceutical Mycophenolate Mofetil Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. Par Pharmaceutical Mycophenolate Mofetil Product

Table 104. Par Pharmaceutical Response to COVID-19 and Related Developments

Table 105. Mycophenolate Mofetil Distributors List

Table 106. Mycophenolate Mofetil Customers List

Table 107. Covid-19 Impact on Mycophenolate Mofetil Customers

List of Figures

Figure 1. Mycophenolate Mofetil Product Picture

Figure 2. Mycophenolate Mofetil Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Mycophenolate Mofetil Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Mycophenolate Mofetil Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Mycophenolate Mofetil Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Mycophenolate Mofetil Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Mycophenolate Mofetil Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Mycophenolate Mofetil Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Mycophenolate Mofetil Market Size Market Share, 2019-2021

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950